Study Coordinator

Alfred Health

Alfred Health is a leader in health care delivery, improvement, research and education. We are the main provider of health services to people living in the inner southeast suburbs of Melbourne, from ambulatory to inpatient and home and community-based services.

• Fixed term (12 months)
• Part Time (60.8 hours per fortnight]
• Alfred Hospital

The Department

The Alfred Brain Program has long been recognised as one of the major clinical and research strengths of Alfred Health. MSNI and Neuro-ophthalmology forms a Core Division in this program.

Clinical services: The MS and Neuroimmunology (MSNI) and Neuro-ophthalmology Services at The Alfred was established in late 2017 and has dramatically expanded. The program delivers a comprehensive research and clinical service that now encompasses outpatient clinics 4 days a week across Alfred campuses. These Alfred Hospital Services pioneered multi-disciplinary services representing best international practice in MS, Neuroimmunology and Neuro-ophthalmology.   The Service includes a range of clinicians including consultants, fellows and specialist nurses.

Research: The MSNI and Neuro-ophthalmology Group is involved in both translational research and clinical trials. Clinical research, including clinical trials and observational practice, are closely integrated with the Department's clinical services - enhancing clinical care outcomes and treatment options for our patients and promoting innovation and advances in neurological practice. Trial activities require dedicated administration and study coordination.

The Role

An opportunity has become available for a Study Coordinator to join the MSNI/Neuro-ophthalmology Research Group at the Department of Neuroscience, Central Clinical School, Monash University.  This is a 0.8 FTE fixed term position from October 2023 to September 2024.  There will be an option to extend this contract. The Study Coordinator will be focused primarily on an MRFF funded study: eVidence synthesis to inform the optimAL UsE of Immunoglobulin (The VALUE-Ig Study). The coordinator will be working on the Myasthenia Gravis Arm of the Study. The aim of the study is to develop heath economic models for immunoglobulin use for a range of conditions in Australia.  The Myasthenia Gravis arm of the study involves four additional Australian sites. 

Skills 

• Proven skills in the management of the activities of a multi-disciplinary team who are engaged in clinical research projects to ensure compliance with protocols and overall clinical objectives.
• Experience in preparation and submission of human research ethics.
• Up to date training in Good Clinical Practice (GCP) and other relevant research training
• Familiarity with the clinical aspects of neurology and relevant sub specialties (epilepsy).
• Strong communication, interpersonal and organisational skills.
• Strong and proven time management skills.
• Have good working knowledge of MS Word, Excel, PowerPoint, and Outlook.

Benefits

• Salary Packaging
• Discount Health Insurance
• Onsite Gym
• Child care services

Applications close 11pm, 29th September 2023

All enquiries to A/ Prof Anneke van der Walt on [email protected]

Alfred Health is an equal opportunity employer and is committed to attracting and retaining a diverse workforce that reflects the community we serve.  Applications from Aboriginal and Torres Strait Islanders are encouraged.

In accordance with the Health Minister's Covid-19 Mandatory Vaccination Order, all Alfred Health employees are required to be fully vaccinated (3 doses) for COVID-19 or hold an acceptable medical exemption. Furthermore, in accordance with the Health Services Amendment (Mandatory Vaccination of Healthcare Workers) Act 2020, health care workers in Category A or B roles (as determined by the department’s risk ratings) are required to be vaccinated against influenza or hold an acceptable medical exemption. 

Website: www.alfredhealth.org.au